RegeneRx Issues Update on ARISE-3 Trial ...Middle East

PR Newswire - News
ROCKVILLE, Md., March 22, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration has posted information on its website regarding the estimated timing of the...

Hence then, the article about regenerx issues update on arise 3 trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RegeneRx Issues Update on ARISE-3 Trial )

Apple Storegoogle play

Last updated :

Also on site :